113 related articles for article (PubMed ID: 8618619)
1. Trandolapril in patients with left ventricular dysfunction after myocardial infarction.
Neumayr G; Gänzer J
N Engl J Med; 1996 Jun; 334(23):1546. PubMed ID: 8618619
[No Abstract] [Full Text] [Related]
2. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
Køber L; Torp-Pedersen C; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J; Cole DS; Auclert L; Pauly NC
N Engl J Med; 1995 Dec; 333(25):1670-6. PubMed ID: 7477219
[TBL] [Abstract][Full Text] [Related]
3. [Trandolapril in patients with left ventricular insufficiency after myocardial infarction].
Aliot E
Arch Mal Coeur Vaiss; 1996 Aug; 89 Spec No 3():23-31. PubMed ID: 8949315
[TBL] [Abstract][Full Text] [Related]
4. [Trandolapril in the prevention of the sequelae of left ventricular systolic dysfunction after acute myocardial infarct].
Buksa M
Med Arh; 2000; 54(2):103-6. PubMed ID: 10934839
[TBL] [Abstract][Full Text] [Related]
5. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
Weir R; McMurray JJ
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
[TBL] [Abstract][Full Text] [Related]
6. Influence of a history of arterial hypertension and pretreatment blood pressure on the effect of angiotensin converting enzyme inhibition after acute myocardial infarction. Trandolapril Cardiac Evaluation Study.
Gustafsson F; Køber L; Torp-Pedersen C; Per Hildebrandt
J Hypertens Suppl; 1998 Jan; 16(1):S65-70. PubMed ID: 9534100
[TBL] [Abstract][Full Text] [Related]
7. The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years.
Buch P; Rasmussen S; Abildstrom SZ; Køber L; Carlsen J; Torp-Pedersen C;
Eur Heart J; 2005 Jan; 26(2):145-52. PubMed ID: 15618070
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibitors in acute myocardial infarction.
Murdoch DR; McMurray JJ
Hosp Med; 1998 Feb; 59(2):111-5. PubMed ID: 9797884
[TBL] [Abstract][Full Text] [Related]
9. Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study.
Sigurdsson A; Eriksson SV; Hall C; Kahan T; Swedberg K
Eur J Heart Fail; 2001 Jan; 3(1):69-78. PubMed ID: 11163738
[TBL] [Abstract][Full Text] [Related]
10. Overview of clinical trials.
Cannon C
J Invasive Cardiol; 2004 Sep; 16 Suppl E():7E-10E. PubMed ID: 23573650
[No Abstract] [Full Text] [Related]
11. Update on pharmacological advances.
Fonarow G
J Invasive Cardiol; 2004 Sep; 16 Suppl E():2E-6E. PubMed ID: 23573649
[No Abstract] [Full Text] [Related]
12. The use of angiotensin converting enzyme inhibitors in asymptomatic patients with left ventricular dysfunction after myocardial infarction.
Bazunga M
Conn Med; 1995 Nov; 59(11):663-6. PubMed ID: 8565511
[No Abstract] [Full Text] [Related]
13. Pharmacologic therapies across the continuum of left ventricular dysfunction.
Abraham WT; Greenberg BH; Yancy CW
Am J Cardiol; 2008 Sep; 102(5A):21G-28G. PubMed ID: 18722188
[TBL] [Abstract][Full Text] [Related]
14. [Ventricular arrhythmias after myocardial infarction: risk classification and treatment concepts].
Seidl K; Hauer B; Schwick N; Buechele T; Schilling I; Senges J
Dtsch Med Wochenschr; 1995 May; 120(18):656-60. PubMed ID: 7750434
[No Abstract] [Full Text] [Related]
15. [The significance of trandelapril for mortality after AMI in patients with reduced left ventricular function. TRACE Study Group].
Køber L; Torp-Pedersen CT; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J
Ugeskr Laeger; 1997 Mar; 159(11):1616-22. PubMed ID: 9092145
[TBL] [Abstract][Full Text] [Related]
16. From left ventricular dysfunction to heart failure.
Cleland JG
Arch Mal Coeur Vaiss; 1996 Nov; 89(11):1397-402. PubMed ID: 9092398
[TBL] [Abstract][Full Text] [Related]
17. Recognizing and managing asymptomatic left ventricular dysfunction after myocardial infarction.
Albert NM; Lewis C
Crit Care Nurse; 2008 Apr; 28(2):20-37; quiz 38. PubMed ID: 18378726
[No Abstract] [Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure.
Thornton PL; Ahmed A
J Am Coll Cardiol; 2004 Apr; 43(7):1333; author reply 1333-4. PubMed ID: 15063454
[No Abstract] [Full Text] [Related]
19. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
20. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M
Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
